Modulation of multidrug resistance by verapamil or mdr1 anti-sense oligodeoxynucleotide does not change the high susceptibility to lymphokine-activated killers in mdr-resistant human carcinoma (LoVo) line

L. Rivoltini, M. P. Colombo, R. Supino, D. Ballinari, T. Tsuruo, G. Parmiani

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Modulation of multidrug resistance by verapamil or mdr1 anti-sense oligodeoxynucleotide does not change the high susceptibility to lymphokine-activated killers in mdr-resistant human carcinoma (LoVo) line'. Together they form a unique fingerprint.

Medicine & Life Sciences